Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemiaArianna Bottoni, George A CalinCurrent Pharmaceutical Design|May 18, 2012
Novel insights in molecular mechanisms of CLLNicola Zanesi, Veronica Balatti, Arianna Bottoni, et al.Human Pathology|October 20, 2012
Primary intrathyroidal paraganglioma: histopathology and novel molecular alterationsStefan Costinean, Veronica Balatti, Arianna Bottoni, et al.Journal of Pharmaceutical and Biomedical Analysis|June 16, 2005
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model systemFederico Tagliati, Arianna Bottoni, Alessandro Bosetti, et al.Journal of Cellular Physiology|January 14, 2005
miR-15a and miR-16-1 down-regulation in pituitary adenomasArianna Bottoni, Daniela Piccin, Federico Tagliati, et al.Endocrinology|March 5, 2005
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinomaMaria Chiara Zatelli, Daniela Piccin, Federico Tagliati, et al.Journal of Cellular Physiology|April 20, 2007
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell linesArianna Bottoni, Cristina Vignali, Daniela Piccin, et al.Endocrinology|April 8, 2006
Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitroFederico Tagliati, Maria Chiara Zatelli, Arianna Bottoni, et al.Cancer Letters|August 25, 2009
Oncosuppressor proteins of fragile sites are reduced in cervical cancerEnrico Giarnieri, Nicola Zanesi, Arianna Bottoni, et al.The Journal of Clinical Endocrinology and Metabolism|August 11, 2005
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanismMaria Chiara Zatelli, Andrea Luchin, Daniela Piccin, et al.Pageof 3